Perceive Pharma

BiotechnologySeries ASan Francisco, US

Latest round

Series A

Last raised

Feb 2025

Total raised

$15M

Investors

6

About Perceive Pharma

Founded in 2023 and based in California, US, Perceive Pharma, Inc. is a biotechnology company that provides pharmaceutical novel small molecule therapeutics. The firm is a spin-off from Perceive Biotherapeutics. In February 2025, Perceive Pharma, Inc. The firm as of February 2025, is eld by its founder and President, Anne (Brody) Rubin. The company focused on developing novel small molecule neuroprotective therapeutics for ophthalmic diseases, with a particular emphasis on glaucoma. The company’s primary focus is to leverage its proprietary screening technology to identify neuroprotective pathways and develop therapies that address unmet needs in ophthalmology. Its lead candidate, PBI-671, targets glaucoma, an eye condition affecting millions, including many with normal intraocular pressure.

Who invested in Perceive Pharma

6 investors across 1 round

See all investors in Perceive Pharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Feb 18, 2025

    Amount

    $15M

    Investors

    Locked

Questions about Perceive Pharma

Who invested in Perceive Pharma?

Perceive Pharma has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Perceive Pharma raised?

Perceive Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Perceive Pharma last raise money?

Perceive Pharma's most recent round on record is a Series A, in Feb 2025.

What does Perceive Pharma do?

Founded in 2023 and based in California, US, Perceive Pharma, Inc.

Where is Perceive Pharma headquartered?

Perceive Pharma is headquartered in San Francisco, US.

Which VCs invest in companies like Perceive Pharma?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Perceive Pharma's stage. Their profiles are linked below.

Raising like Perceive Pharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.